Physician profile

Michael J Johnson

Orthopaedic Surgery · Salina, KS

NPI 1063440246

$525.20

in general payments reported to CMS, 2019-2025

10 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$118.38

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Zimmer Biomet Holdings, INC. $126.52 2022
Amgen INC. $118.38 2024 Evenity
Encore Medical, LP $72.44 2022
Stryker Corporation $66.86 2019
Ethicon US, LLC $44.02 2019
Convatec INC. $26.79 2019
Titan Surgical Group, LLC $25.71 2019
Pacira Therapeutics, INC. $16.25 2020
Pacira Pharmaceuticals Incorporated $15.11 2021
Depuy Synthes Sales INC. $13.12 2019

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Michael J Johnson

$525.20

in general payments reported 2019-2025

Years
2019-2024
Top company
Zimmer Biomet Holdings, INC.

https://glasscript.com/doctor/93720/michael-j-johnson

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.